Evidence map›Paper›PMID 39453425›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2024

Diabetes mellitus disrupts lncRNA Malat1 regulation of cardiac mitochondrial genome-encoded protein expression.

Andrew D Taylor, Quincy A Hathaway, Ethan M Meadows, Andrya J Durr, Amina Kunovac, Mark V Pinti, Chris C Cook, Brianna R Miller, Remi Nohoesu, Roxy Nicoletti and 3 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Guidelines for diet-induced models of cardiometabolic syndrome.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andrew D TaylorDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0002-8207-3822
Quincy A HathawayDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0001-8226-2319
Ethan M MeadowsMitochondria, Metabolism & Bioenergetics Working Group, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0001-9633-7596
Andrya J DurrDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0002-4672-6435
Amina KunovacDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.
Mark V PintiMitochondria, Metabolism & Bioenergetics Working Group, West Virginia University School of Medicine, Morgantown, West Virginia, United States.
Chris C CookCardiovascular and Thoracic Surgery, West Virginia University School of Medicine, Morgantown, West Virginia, United States.
Brianna R MillerDepartment of Biochemistry, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0001-9957-0916
Remi NohoesuDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0003-1654-4128
Roxy NicolettiDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0001-5305-3569
Hafsat O AlabereDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.
Aaron R RobartDepartment of Biochemistry, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0002-0518-3972
John M HollanderDivision of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States.ORCID 0000-0001-5724-694X

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
WVU Flow Cytometry and Single Cell Core Facility (FCSCCF)P20GM121322 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Karen H Martin · 2018 to 2026
$22.4M
VS-CoBRE Administrative CoreP20GM144230 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Visvanathan Ramamurthy · 2022 to 2026
$13.9M
Role of Protein Import in the Development of the Diabetic HeartR01HL168290 · NHLBI · WEST VIRGINIA UNIVERSITY · PI John M Hollander · 2023 to 2026
$2.2M
Mechanisms of Splicing and RetrotranspositionR01GM133857 · NIGMS · WEST VIRGINIA UNIVERSITY · PI ROBART, AARON REIGH · 2019 to 2023
$1.6M
Influence of Particulate Matter on Fetal Mitochondrial ProgrammingR01ES034628 · NIEHS · WEST VIRGINIA UNIVERSITY · PI John M Hollander · 2023 to 2026
$1.4M
miRNA Regulation of the Mitochondrial GenomeR01HL128485 · NHLBI · WEST VIRGINIA UNIVERSITY · PI HOLLANDER, JOHN M · 2017 to 2019
$1.3M
Pre-doctoral Training in Systems ToxicologyT32ES032920 · NIEHS · WEST VIRGINIA UNIVERSITY · PI Timothy R Nurkiewicz · 2022 to 2026
$1.2M
American Heart Association (AHA) 829079American Heart Association (AHA) AHA-17PRE33660333American Heart Association (AHA) AHA-20PRE35080170American Heart Association-American Stroke Association 17PRE33660333Community Foundation for the Ohio Valley Whipkey TrustHHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01 HL-128485HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01 HL-168290HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) R01 ES-034628HHS | NIH | National Institute of General Medical Sciences (NIGMS) R01GM133857NHLBI NIH HHS R01 HL128485NHLBI NIH HHS R01 HL168290NIEHS NIH HHS R01 ES034628NIEHS NIH HHS T32 ES032920NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P20 GM121322NIGMS NIH HHS P20 GM144230NIGMS NIH HHS R01 GM133857NIGMS NIH HHS U54 GM104942West Virginia Clinical and Translational Science Institute (WVCTSI) U54GM104942West Virginia IDeA Network of Biomedical Research WV-INBRE |NIH| P20GM103434WVU Cancer Institute | WVU HSC Office of Research and Graduate Education |NIH| P20GM121322WVU Cancer Institute | WVU HSC Office of Research and Graduate Education |NIH| P20GM144230WVU Cancer Institute | WVU HSC Office of Research and Graduate Education |NIH| U54GM104942
6 · The paper itself

Abstract

Understanding the cellular mechanisms behind diabetes-related cardiomyopathy is crucial as it is a common and deadly complication of diabetes mellitus. Dysregulation of the mitochondrial genome has been linked to diabetic cardiomyopathy and can be ameliorated by altering microRNA (miRNA) availability in the mitochondrion. Long noncoding RNAs (lncRNAs) have been identified to downregulate miRNAs. This study aimed to determine if diabetes mellitus impacts the mitochondrial localization of lncRNAs, their interaction with miRNAs, and how this influences mitochondrial and cardiac function. In mouse and human nondiabetic and type 2 diabetic cardiac tissue, RNA was isolated from purified mitochondria and sequenced (Ilumina HiSeq). Malat1 was significantly downregulated in both human and mouse cardiac mitochondria. The use of a mouse model with an insertional deletion of Malat1 transcript expression resulted in exacerbated systolic and diastolic dysfunction when evaluated in conjunction with a high-fat diet. The cardiac effects of a high-fat diet were countered in a mouse model with transgenic overexpression of Malat1. MiR-320a, a miRNA that binds to both mitochondrial genome-encoded gene NADH-ubiquinone oxidoreductase chain 1 (MT-ND1) as well as Malat1, was upregulated in human and mouse diabetic mitochondria. Conversely, MT-ND1 was downregulated in human and mouse diabetic mitochondria. Mice with an insertional inactivation of Malat1 displayed increased recruitment of both miR-320a and MT-ND1 to the RNA-induced silencing complex (RISC). In vitro pulldown assays of Malat1 fragments with conserved secondary structure confirmed binding capacity for miR-320a. In vitro Seahorse assays indicated that Malat1 knockdown and miR-320a overexpression impaired overall mitochondrial bioenergetics and Complex I functionality. In summary, the disruption of Malat1 presence in mitochondria, as observed in diabetic cardiomyopathy, is linked to cardiac dysfunction and mitochondrial genome regulation.

Indexed as

Diabetic CardiomyopathiesMicroRNAsMitochondria, HeartRNA, Long NoncodingAnimalsDiabetes Mellitus, Type 2Diet, High-FatGene Expression RegulationGenome, MitochondrialHumansMaleMiceMice, Inbred C57BLMitochondrial ProteinsMyocytes, CardiacMALAT1 long non-coding RNA, humanMalat1 long non-coding RNA, mouseMicroRNAsMitochondrial ProteinsRNA, Long NoncodingheartLncRNAMalat1miRNAmitochondria

Identifiers

PMID39453425
PMCPMC11684948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.